58 related articles for article (PubMed ID: 9550487)
21. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
Di Martino V; Rufat P; Boyer N; Renard P; Degos F; Martinot-Peignoux M; Matheron S; Le Moing V; Vachon F; Degott C; Valla D; Marcellin P
Hepatology; 2001 Dec; 34(6):1193-9. PubMed ID: 11732009
[TBL] [Abstract][Full Text] [Related]
22. GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease.
Berzsenyi MD; Bowden DS; Roberts SK; Revill PA
J Gastroenterol Hepatol; 2009 Aug; 24(8):1407-10. PubMed ID: 19702909
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology, clinical and laboratory characteristics of currently alive HIV-1 infected former blood donors naive to antiretroviral therapy in Anhui Province, China.
Xu JQ; Wang JJ; Han LF; Xu C; Ruan YH; Xu ZH; Chen X; Liu ZD; Wang J; Su B; Ding XP; Gao B; Gu YB; Cao XY; Xing H; Hong KX; Peng H; Zhao QB; Yuan L; Feng Y; Zhang GY; Ma LY; Wu L; Shao YM
Chin Med J (Engl); 2006 Dec; 119(23):1941-8. PubMed ID: 17199937
[TBL] [Abstract][Full Text] [Related]
24. Sustained disappearance of hepatitis C viremia in patients receiving protease inhibitor treatment for human immunodeficiency virus infection.
Fialaire P; Payan C; Vitour D; Chennebault JM; Loison J; Pichard E; Lunel F
J Infect Dis; 1999 Aug; 180(2):574-5. PubMed ID: 10395889
[No Abstract] [Full Text] [Related]
25. High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART?
Bani-Sadr F; Goderel I; Morand P; Payan C; Lunel F; Pol S; Perronne C; Carrat F; Cacoub P
AIDS; 2007 Jul; 21(12):1645-8. PubMed ID: 17630563
[TBL] [Abstract][Full Text] [Related]
26. Decreased prevalence of mixed cryoglobulinemia in the HAART era among HIV-positive, HCV-negative patients.
Kosmas N; Kontos A; Panayiotakopoulos G; Dimitrakopoulos A; Kordossis T
J Med Virol; 2006 Oct; 78(10):1257-61. PubMed ID: 16927287
[TBL] [Abstract][Full Text] [Related]
27. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
[TBL] [Abstract][Full Text] [Related]
28. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
[TBL] [Abstract][Full Text] [Related]
29. Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1-infected individuals.
Tornero C; Alberola J; Tamarit A; Navarro D
Clin Microbiol Infect; 2006 Jun; 12(6):555-60. PubMed ID: 16700705
[TBL] [Abstract][Full Text] [Related]
30. [Can alpha-interferon exacerbate a case of mixed cryoglobulinemia?].
Romagno D; Dicillo M; Lucchese G; Cecere O; Mongelli A
Recenti Prog Med; 1992 Nov; 83(11):654-5. PubMed ID: 1287757
[TBL] [Abstract][Full Text] [Related]
31. Disappearance of cryoglobulins and remission of symptoms in a patient with HCV-associated type II mixed cryoglobulinemia after HIV-1 infection.
Antinori S; Galimberti L; Rusconi S; Zehender G; Esposito R; Galli M
Clin Exp Rheumatol; 1995; 13 Suppl 13():S157-9. PubMed ID: 8730498
[TBL] [Abstract][Full Text] [Related]
32. [Mixed cryoglobulinemia and hepatitis C virus].
Muñoz Fernández S; Gijón Baños J
Med Clin (Barc); 1993 Nov; 101(18):697-8. PubMed ID: 8114527
[No Abstract] [Full Text] [Related]
33. Mixed cryoglobulinemia secondary to interferon therapy for hepatitis C: case report & review of the literature.
Kimyai-Asadi A; Gohar K; Kang P; Usman A; Zenenberg R; Jih MH
J Drugs Dermatol; 2002 Jul; 1(1):72-5. PubMed ID: 12847761
[TBL] [Abstract][Full Text] [Related]
34. [Red fingers syndrome in the course of HIV infection. A new case].
Lair G; Levesque H; Lecomte F; Cailleux N; Gueit I; Delbarre M; Humbert G; Courtois H
J Mal Vasc; 1997 Mar; 22(1):48-50. PubMed ID: 9120372
[TBL] [Abstract][Full Text] [Related]
35. Septic bursitis, a potential complication of protease inhibitor use in hepatitis C virus.
Burke CC; Martel-Laferriere V; Dieterich DT
Clin Infect Dis; 2013 May; 56(10):1507-8. PubMed ID: 23413416
[No Abstract] [Full Text] [Related]
36. Mixed cryoglobulinemia: a diagnostic and therapeutic challenge.
Túlio M; Carvalho L; Bana E Costa T; Chagas C
BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28490478
[TBL] [Abstract][Full Text] [Related]
37. Mononeuritis multiplex associated with cryoglobulinemia in HIV infection.
Stricker RB; Sanders KA; Owen WF; Kiprov DD; Miller RG
Neurology; 1992 Nov; 42(11):2103-5. PubMed ID: 1436518
[TBL] [Abstract][Full Text] [Related]
38. Peripheral neuropathy associated with cryoglobulinaemia but not related to hepatitis C virus in an HIV-infected patient.
Le Lostec Z; Fegueux S; Vitale C; Geoffroy O; Bleton F; Mornet P
AIDS; 1994 Sep; 8(9):1351-2. PubMed ID: 7802997
[No Abstract] [Full Text] [Related]
39. Expression of the stromal cell-derived factor-1 receptor (CXCR4) on peripheral lymphocytes of patients with hepatitis-C-virus-associated mixed cryoglobulinaemia.
Porretti L; Lopa R; Maiocchi M; Di Cataldo D; Scalamogna M; Prati D
Dig Liver Dis; 2003 May; 35(5):370-1. PubMed ID: 12846411
[No Abstract] [Full Text] [Related]
40. [Artificial increase in leukocyte and platelet counts disclosing type II cryoglobulinemia].
Zandecki M; Dupriez B; Demory JL; Haffreingue H; Cosson A
Presse Med; 1989 Oct; 18(35):1756. PubMed ID: 2531396
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
